Join
Live feed
·
INSIDERFilingvia Quantisnow
Travere Therapeutics Inc. logo

CHIEF COMMERCIAL OFFICER Heerma Peter sold $101,417 worth of shares (2,174 units at $46.65) and converted options into 4,250 shares, increasing direct ownership by 1% to 140,684 units (SEC Form 4) (withholding obligation)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TVTX (Travere Therapeutics Inc.) and more on Quantisnow.